Forest Ray

4 days ago | genomeweb.com | Forest Ray

NEW YORK – Data from several clinical trials presented at the American Society of Clinical Oncology's annual meeting this week support the use of circulating tumor DNA (ctDNA) to guide therapy decisions before clinical progression in early and metastatic breast cancer.

1 week ago | genomeweb.com | Forest Ray

NEW YORK – Geneseeq sees a path to broader commercialization of its CanScan liquid biopsy multicancer early detection (MCED) test, following encouraging interim data from an ongoing multiphase study taking place in China that was published this week in Nature. The multiphase study aims to determine the feasibility of MCED testing using Geneseeq's CanScan assay in an outpatient setting, targeting asymptomatic adults between the ages of 45 and 75.

2 weeks ago | genomeweb.com | Forest Ray

NEW YORK – A novel cell segmentation method developed by scientists at the Fred Hutchinson Cancer Center may help researchers conduct more accurate spatial biology studies, advancing key efforts such as cancer biomarker and drug target discovery. Cell segmentation is a fundamental first step in understanding spatial gene expression; essentially, which mRNA transcripts come from which cell.

2 weeks ago | genomeweb.com | Forest Ray

NEW YORK – Skin analytics company Mindera Health recently demonstrated the clinical utility of its flagship Mind.Px lab-developed test and is now focused on expanding its access while planning a longer durability study. The Mind.Px test consists of a patch, approximately the size of a penny, covered with a 10-by-10 array of minuscule needle-like projections that are pushed via an applicator 350 to 400 micrometers into the skin and held for five minutes.

3 weeks ago | genomeweb.com | Forest Ray

NEW YORK – Without a significant cash infusion, international genomics research nonprofit Global Genomics Medicine Collaborative (G2MC) runs out of money and will likely have to close its operations in approximately nine weeks' time.